378 related articles for article (PubMed ID: 31729963)
1. A gene expression-based study on immune cell subtypes and glioma prognosis.
Zhong QY; Fan EX; Feng GY; Chen QY; Gou XX; Yue GJ; Zhang GH
BMC Cancer; 2019 Nov; 19(1):1116. PubMed ID: 31729963
[TBL] [Abstract][Full Text] [Related]
2. [Establishment of a prediction model for colorectal cancer immune cell infiltration based on the cancer genome atlas (TCGA) database].
Ding TT; Zeng CX; Hu LN; Yu MH
Beijing Da Xue Xue Bao Yi Xue Ban; 2022 Apr; 54(2):203-208. PubMed ID: 35435180
[TBL] [Abstract][Full Text] [Related]
3. A Transcriptional Signature of PDGF-DD Activated Natural Killer Cells Predicts More Favorable Prognosis in Low-Grade Glioma.
Sun Y; Sedgwick AJ; Palarasah Y; Mangiola S; Barrow AD
Front Immunol; 2021; 12():668391. PubMed ID: 34539622
[TBL] [Abstract][Full Text] [Related]
4. LAYN Is a Prognostic Biomarker and Correlated With Immune Infiltrates in Gastric and Colon Cancers.
Pan JH; Zhou H; Cooper L; Huang JL; Zhu SB; Zhao XX; Ding H; Pan YL; Rong L
Front Immunol; 2019; 10():6. PubMed ID: 30761122
[No Abstract] [Full Text] [Related]
5. The pro-invasive factor COL6A2 serves as a novel prognostic marker of glioma.
Zhu J; Lin Q; Zheng H; Rao Y; Ji T
Front Oncol; 2022; 12():897042. PubMed ID: 36505882
[TBL] [Abstract][Full Text] [Related]
6. Prognostic Gene Expression Signature in Patients With Distinct Glioma Grades.
Ait Ssi S; Chraa D; El Azhary K; Sahraoui S; Olive D; Badou A
Front Immunol; 2021; 12():685213. PubMed ID: 34539626
[TBL] [Abstract][Full Text] [Related]
7. Comprehensive Analysis of Tumor-Infiltrating Immune Cells and Relevant Therapeutic Strategy in Esophageal Cancer.
Lu G; Chen L; Wu S; Feng Y; Lin T
Dis Markers; 2020; 2020():8974793. PubMed ID: 32454908
[TBL] [Abstract][Full Text] [Related]
8. Profiles of immune cell infiltration in head and neck squamous carcinoma.
Liang B; Tao Y; Wang T
Biosci Rep; 2020 Feb; 40(2):. PubMed ID: 32095823
[TBL] [Abstract][Full Text] [Related]
9. Machine learning-based identification of a cell death-related signature associated with prognosis and immune infiltration in glioma.
Zhou Q; Wu F; Zhang W; Guo Y; Jiang X; Yan X; Ke Y
J Cell Mol Med; 2024 Jun; 28(11):e18463. PubMed ID: 38847472
[TBL] [Abstract][Full Text] [Related]
10. Immune Cell Composition in Human Non-small Cell Lung Cancer.
Stankovic B; Bjørhovde HAK; Skarshaug R; Aamodt H; Frafjord A; Müller E; Hammarström C; Beraki K; Bækkevold ES; Woldbæk PR; Helland Å; Brustugun OT; Øynebråten I; Corthay A
Front Immunol; 2018; 9():3101. PubMed ID: 30774636
[TBL] [Abstract][Full Text] [Related]
11. The establishment of immune infiltration based novel recurrence predicting nomogram in prostate cancer.
Meng J; Liu Y; Guan S; Fan S; Zhou J; Zhang M; Liang C
Cancer Med; 2019 Sep; 8(11):5202-5213. PubMed ID: 31355524
[TBL] [Abstract][Full Text] [Related]
12. Identification of three molecular subtypes based on immune infiltration in ovarian cancer and its prognostic value.
Liu J; Tan Z; He J; Jin T; Han Y; Hu L; Song J; Huang S
Biosci Rep; 2020 Oct; 40(10):. PubMed ID: 33043974
[TBL] [Abstract][Full Text] [Related]
13. SYT16 is a prognostic biomarker and correlated with immune infiltrates in glioma: A study based on TCGA data.
Chen J; Wang Z; Wang W; Ren S; Xue J; Zhong L; Jiang T; Wei H; Zhang C
Int Immunopharmacol; 2020 Jul; 84():106490. PubMed ID: 32289666
[TBL] [Abstract][Full Text] [Related]
14. Tissue-infiltrating immune cells as prognostic markers in oral squamous cell carcinoma: a systematic review and meta-analysis.
Hadler-Olsen E; Wirsing AM
Br J Cancer; 2019 Apr; 120(7):714-727. PubMed ID: 30808992
[TBL] [Abstract][Full Text] [Related]
15. Prognostic value of tumor infiltrating NK cells and macrophages in stage II+III esophageal cancer patients.
Xu B; Chen L; Li J; Zheng X; Shi L; Wu C; Jiang J
Oncotarget; 2016 Nov; 7(46):74904-74916. PubMed ID: 27736796
[TBL] [Abstract][Full Text] [Related]
16. Immune Cell Confrontation in the Papillary Thyroid Carcinoma Microenvironment.
Xie Z; Li X; He Y; Wu S; Wang S; Sun J; He Y; Lun Y; Zhang J
Front Endocrinol (Lausanne); 2020; 11():570604. PubMed ID: 33193087
[TBL] [Abstract][Full Text] [Related]
17. An Individualized Immune Prognostic Index is a Superior Predictor of Survival of Hepatocellular Carcinoma.
Wang X; Wu Y; Wen D; Wu LY; Zhao Y; He Y; Yang H
Med Sci Monit; 2020 May; 26():e921786. PubMed ID: 32527991
[TBL] [Abstract][Full Text] [Related]
18. Study on the Prognostic Values of Dynactin Genes in Low-Grade Glioma.
Su X; Li H; Chen S; Qin C
Technol Cancer Res Treat; 2021; 20():15330338211010143. PubMed ID: 33896271
[TBL] [Abstract][Full Text] [Related]
19. Profiles of immune cell infiltration and immune-related genes in the tumor microenvironment of osteosarcoma.
Zhang C; Zheng JH; Lin ZH; Lv HY; Ye ZM; Chen YP; Zhang XY
Aging (Albany NY); 2020 Feb; 12(4):3486-3501. PubMed ID: 32039832
[TBL] [Abstract][Full Text] [Related]
20. Prognostic Value of Metabolism-Related Genes and Immune Infiltration in Clear Cell Renal Cell Carcinoma.
Li H; Mo Z
Int J Gen Med; 2021; 14():6885-6898. PubMed ID: 34703293
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
